MENU
+Compare
ROIV
Stock ticker: NASDAQ
AS OF
Aug 11, 01:58 PM (EDT)
Price
$11.28
Change
-$0.22 (-1.91%)
Capitalization
7.84B

ROIV Roivant Sciences Ltd Forecast, Technical & Fundamental Analysis

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients... Show more

ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ROIV with price predictions
Aug 08, 2025

ROIV's Stochastic Oscillator is staying in overbought zone for 2 days

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ROIV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ROIV broke above its upper Bollinger Band on August 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 04, 2025. You may want to consider a long position or call options on ROIV as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ROIV just turned positive on August 05, 2025. Looking at past instances where ROIV's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

ROIV moved above its 50-day moving average on July 09, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ROIV crossed bullishly above the 50-day moving average on July 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for ROIV moved above the 200-day moving average on July 23, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ROIV advanced for three days, in of 244 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ROIV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.673) is normal, around the industry mean (18.662). P/E Ratio (1.966) is within average values for comparable stocks, (54.033). ROIV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (285.714) is also within normal values, averaging (286.048).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ROIV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ROIV is expected to report earnings to fall 15.07% to -24 cents per share on August 11

Roivant Sciences Ltd ROIV Stock Earnings Reports
Q2'25
Est.
$-0.25
Q1'25
Missed
by $0.03
Q4'24
Beat
by $0.48
Q3'24
Missed
by $0.02
Q2'24
Beat
by $0.36
The last earnings report on May 29 showed earnings per share of -28 cents, missing the estimate of -26 cents. With 1.33M shares outstanding, the current market capitalization sits at 7.84B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
50 Broadway
Phone
+44 2074003347
Employees
904
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DRLL27.250.04
+0.15%
Strive U.S. Energy ETF
PFI55.530.06
+0.11%
Invesco Dorsey Wright Financial Momt ETF
TUSB50.380.04
+0.08%
Thrivent Ultra Short Bond ETF
LGLV175.05N/A
N/A
SPDR® SSGA US Large Cap Low Volatil ETF
IBRN23.74N/A
N/A
iShares Neuroscience and Healthcare ETF

ROIV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-0.52%
IMVT - ROIV
60%
Loosely correlated
N/A
ACLX - ROIV
54%
Loosely correlated
-0.91%
CRNX - ROIV
52%
Loosely correlated
-3.69%
KYMR - ROIV
50%
Loosely correlated
-0.56%
NUVL - ROIV
49%
Loosely correlated
+2.70%
More

Groups containing ROIV

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-0.52%
ROIV
(2 stocks)
75%
Closely correlated
-2.80%